Sellbyville, Delaware, Jan. 17, 2018 (GLOBE NEWSWIRE) --
Global Diabetic Retinopathy Market is projected to cross USD 11 billion by 2024; according to a new research report by Global Market Insights. Increasing geriatric population base coupled with rising incidences of age related macular degeneration (AMD) and diabetes will drive diabetic retinopathy market over the coming years. Technological advancements pertaining to diabetic retinopathy treatment and increasing research activities towards developing innovative products for treating vision loss due to diabetes will fuel market growth.
Numerous efforts made by organizations such as Canadian Diabetes Association to provide guidelines for diabetic retinopathy screening to patients suffering from diabetes will favour industry growth. Diabetic eye screening program, and other awareness campaigns arranged by government to reduce disease prevalence will further propel industry growth.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/486
Urbanization, unhealthy eating habits and physical inactivity has surged number of people suffering from chronic conditions such as diabetes. Factors such as prolonged undiagnosed diabetes, ignorance towards treatment and uncontrolled glucose levels will accelerate incidences of diabetes retinopathy over the coming years. However stringent approval procedure and dearth of skilled ophthalmologists will hinder diabetic retinopathy market growth over the forecast timeframe.
Browse key industry insights spread across 90 pages with 53 market data tables & 10 figures & charts from the report, “Diabetic Retinopathy Market” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/diabetic-retinopathy-market-report
Non-proliferative diabetic retinopathy market dominated the market in 2016 and is expected to show considerable growth over the coming years. Rising diabetic population as well as increasing number of people suffering from diabetic retinopathy will drive non-proliferative diabetic retinopathy market.
Laser surgery segment is anticipated to witness significant growth over the forecast period due to rising adoption of lasers in various healthcare settings for treatment of diabetic macular edema (DME). Technological advancements in laser treatment to detect eye diseases pre-occurrence of vision loss will further boost market growth. Growing incidences of advanced proliferative diabetic retinopathy will drive vitrectomy segment over the coming years.
UK diabetic retinopathy market should witness robust growth over the forecast period. High technological adoption coupled with rising number of people suffering from diabetic retinopathy will drive UK diabetic retinopathy market. Government initiatives including programs such as ‘Action for Diabetes’ undertaken to aware people about diabetic associated blindness will positively impact industry growth.
Growing geriatric population base along with growing prevalence of diabetes will drive Japanese diabetic retinopathy market over the forecast period. Increasing application of vitrectomy for treating diabetic macular edema in the country will further boost market growth.
Some of the industry players operating in global diabetic retinopathy market are Allergan, Novartis, Bayer, Genentech and Regeneron Pharmaceuticals.
The companies operating in diabetic retinopathy market are focusing on developing new innovative products by adopting strategies such as strategic collaborations, partnerships and acquisition. For instance, Novartis acquired Encore Vision in December 2016 to strengthen its ophthalmic product portfolio. At present, several research projects are being conducted to identify exact inhibitor that leads diabetes to vision loss.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/486
Browse Related Reports:
- Pen Needles Market Size 2017 – 2024
Pen Needles Market share is expected to experience significant growth from 2017 to 2024. Increasing worldwide prevalence of diabetes and obesity will spur pen needles market growth during the forecast period.
https://www.gminsights.com/industry-analysis/pen-needles-market
- Insulin Delivery Devices Market Size 2017 – 2024
Insulin Delivery Devices Market share is expected to witness a moderate growth over the forecast period. Increasing diabetes prevalence will drive insulin delivery devices market growth throughout the forecast period.
https://www.gminsights.com/industry-analysis/insulin-delivery-devices-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Connect with us: Facebook | Google+ | LinkedIn | Twitter